Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 18 studies | 56% ± 19% | |
glutamatergic neuron | 9 studies | 43% ± 25% | |
neuron | 4 studies | 18% ± 2% | |
GABAergic neuron | 3 studies | 44% ± 8% | |
ependymal cell | 3 studies | 73% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 35% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 823.78 | 652 / 653 | 43% | 0.77 | 258 / 605 |
kidney | 98% | 265.00 | 87 / 89 | 30% | 0.57 | 267 / 901 |
ovary | 91% | 235.87 | 163 / 180 | 27% | 0.60 | 116 / 430 |
prostate | 89% | 220.77 | 217 / 245 | 25% | 0.44 | 127 / 502 |
uterus | 91% | 303.41 | 154 / 170 | 15% | 0.44 | 67 / 459 |
brain | 82% | 424.84 | 2176 / 2642 | 17% | 0.46 | 120 / 705 |
pancreas | 86% | 130.26 | 283 / 328 | 10% | 0.18 | 17 / 178 |
lung | 77% | 559.09 | 447 / 578 | 18% | 0.57 | 210 / 1155 |
liver | 74% | 219.10 | 167 / 226 | 19% | 0.46 | 76 / 406 |
breast | 77% | 198.54 | 354 / 459 | 15% | 0.29 | 166 / 1118 |
stomach | 65% | 89.50 | 233 / 359 | 15% | 0.36 | 44 / 286 |
intestine | 54% | 71.72 | 522 / 966 | 14% | 0.26 | 76 / 527 |
bladder | 62% | 68.29 | 13 / 21 | 6% | 0.14 | 32 / 504 |
adipose | 58% | 94.16 | 697 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 26% | 32.28 | 66 / 258 | 17% | 0.28 | 40 / 230 |
skin | 24% | 23.02 | 430 / 1809 | 7% | 0.28 | 32 / 472 |
esophagus | 14% | 13.97 | 206 / 1445 | 15% | 0.27 | 27 / 183 |
spleen | 20% | 17.43 | 47 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 18% | 18.76 | 235 / 1335 | 0% | 0 | 0 / 0 |
heart | 13% | 12.13 | 109 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 12% | 15.88 | 109 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.04 | 1 / 45 |
muscle | 1% | 0.74 | 7 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060294 | Biological process | cilium movement involved in cell motility |
GO_0005930 | Cellular component | axoneme |
GO_0030286 | Cellular component | dynein complex |
GO_0097729 | Cellular component | 9+2 motile cilium |
GO_0005874 | Cellular component | microtubule |
GO_0051959 | Molecular function | dynein light intermediate chain binding |
GO_0008569 | Molecular function | minus-end-directed microtubule motor activity |
GO_0045505 | Molecular function | dynein intermediate chain binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | DNAH6 |
Protein name | Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6) |
Synonyms | DNAHC6 HL2 DNHL1 KIAA1697 |
Description | FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP (By similarity). . |
Accessions | ENST00000389394.8 [Q9C0G6-1] Q9C0G6 |